Zydus Lifesciences gets USFDA nod for generic drug to prevent chest pain in heart patients

Zydus Lifesciences Ltd announced on Friday that it has attained final approval from the US health regulatory authority to produce and distribute its generic Isosorbide Mononitrate extended-release tablets. These tablets are utilized for preventing chest pain in patients with specific heart conditions.
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news